MedTrace Logo

Performance and Tolerability of a New Medical Device Gel, a Randomized, Open Label, Parallel-group, Multicentre Study

NCT03423784 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2018-05-17

No results posted yet for this study

Summary

Medical device study for efficacy and tolerability of a HA gel in the management of teething symptoms

Conditions

  • Tooth Disease

Interventions

DEVICE

HA BPX V3.3

medical device containing HA

OTHER

Dentinox-Gel N

Anaesthetic gel

Sponsors & Collaborators

  • Opera CRO, a TIGERMED Group Company

    lead OTHER

Principal Investigators

  • Rosu Serban, MD · SCM Dr. ROSU

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
3 Months
Max Age
36 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-15
Primary Completion
2015-03-31
Completion
2015-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03423784 on ClinicalTrials.gov